SEARCH

SEARCH BY CITATION

References

  • Birnstiel S, Wulfert E, Beck SG (1997). Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn Schmiedebergs Arch Pharmacol 356: 611618.
  • Gillard M, Chatelain P, Fuks B (2006). Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Eur J Pharmacol 536: 102108.
  • Gower AJ, Hirsch E, Boehrer A, Noyer M, Marescaux C (1995). Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 22: 207213.
  • Hönack D, Löscher W (1995). Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia 36: 763771.
  • Kenda BM, Matagne AC, Talaga PE, Pasau PM, Differding E, Lallemand BI et al. (2004). Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. J Med Chem 47: 530549.
  • Klitgaard H (2001). Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 42 (Suppl 4): 1318.
  • Klitgaard H, Matagne A, Gobert J, Wulfert E (1998). Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 353: 191206.
  • Klitgaard H, Matagne A, Lamberty Y (2002a). Use of epileptic animals for adverse effect testing. Epilepsy Res 50: 5565.
  • Klitgaard H, Matagne A, Vanneste-Goemaere J, Margineanu DG (2002b). Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations. Epilepsy Res 51: 93107.
  • Klitgaard H, Verdru P (2007). Levetiracetam: the first SV2A ligand for the treatment of epilepsy. Expert Opin Drug Discov 2: 15371545.
  • Kostyuk PG, Lukyanetz EA, Klitgaard H, Margineanu D-G (2004). UCB 34714, a new pyrrolidone derivative, without impact on high- and low-voltage activated calcium currents in rat isolated neurons. Epilepsia 45 (Suppl 7): 141.
  • Leclercq K, Dassesse D, Lambeng N, Klitgaard H, Matagne A (2006). Unaltered Seizure Susceptibility Contrasts Accelerated Kindling Acquisition in Heterozygous SV2A KO Mice. Society for Neurosciences: Washington DC.
  • Löscher W, Hönack D (1991). Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther 256: 432440.
  • Löscher W, Hönack D, Rundfeldt C (1998). Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 284: 474479.
  • Löscher W, Jackel R, Czuczwar SJ (1986). Is amygdala kindling in rats a model for drug-resistant partial epilepsy? Exp Neurol 93: 211226.
  • Löscher W, Schmidt D (1994). Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 17: 95134.
  • Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A et al. (2004). The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101: 98619866.
  • Margineanu D-G, Klitgaard H (2000). Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 42: 281285.
  • Margineanu DG, Klitgaard H (2001). Can gap-junction blockade preferentially inhibit neuronal hypersynchrony vs excitability? Neuropharmacology 41: 377383.
  • Margineanu DG, Niespodziany I, Wülfert E (1998). Antagonism by levetiracetam (ucb L059) of bicuculline-induced epileptiform activity in rat hippocampus requires activation of corticoid receptors. Soc Neurosci Abs 24: 769.16.1940.
  • Margineanu D-G, Schlobohm I, Klitgaard H (2004). UCB 34714, a new pyrrolidone anticonvulsant had no effect on voltage-gated potassium currents in cultured mouse hippocampal neurons. Epilepsia 45 (Suppl 3): 116.
  • Matagne A, Klitgaard H (1998). Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man. Epilepsy Res 31: 5971.
  • Meldrum BS, Rogawski MA (2007). Molecular targets for antiepileptic drug development. Neurotherapeutics 4: 1861.
  • Noyer M, Gillard M, Matagne A, Henichart JP, Wülfert E (1995). The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol 286: 137146.
  • Paxinos G, Watson C (1982). The Rat Brain in Stereotactic Coordinates. Academic Press: Australia.
  • Racine RJ (1972). Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281294.
  • Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B et al. (2002). The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136: 659672.
  • Rigo JM, Nguyen L, Hans G, Belachew S, Moonen G, Matagne A et al. (2004). UCB 34714: effect on inhibitory and excitatory neurotransmission. Epilepsia 45 (Suppl 3): 56.
  • Sargentini-Maier ML, Rolan P, Connell J, Tytgat D, Jacobs T, Pigeolet E et al. (2007). The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males. Br J Clin Pharmacol 63: 680688.
  • Silver JM, Shin C, McNamara JO (1991). Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy. Ann Neurol 29: 356363.
  • Stratton SC, Large CH, Cox B, Davies G, Hagan RM (2003). Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model. Epilepsy Res 53: 95106.
  • Walker MC, White HS, Sander JW (2002). Disease modification in partial epilepsy. Brain 125: 19371950.
  • Zona C, Pieri M, Klitgaard H, Margineanu D-G (2004). UCB 34714, a new pyrrolidone derivative, inhibits Na+ currents in rat cortical neurons in culture. Epilepsia 45 (Suppl 7): 146.